Home  >  News
  US FDA warns Zhejiang Huahai Pharma on manufacturing violations of API valsartan,   December 13, 2018
  OBT expands collaboration with WuXi Biologics and licenses WuXiBody Platform for 5 bispecific antibody programmes,   December 12, 2018
  PharmaMar receives Australian approval for Aplidin to treat multiple myeloma,   December 12, 2018
  US FDA announces new framework to advance use of RWE to support development of drugs & biologics,   December 10, 2018
  US FDA Commissioner's statement on new effort for developing, class labelling of in vitro companion diagnostics for classes of oncology therapeutic products,   December 08, 2018
  Biogen obtains royalty-bearing license from Ionis to develop & commercialize BIIB067 to treat ALS with SOD1 mutations,   December 08, 2018
  Gilead's HIV drug Descovy receives Chinese approval,   December 06, 2018
  Phase 3 trial finds ibrutinib in combo with rituximab superior to standard treatment for some patients with CLL,   December 06, 2018
  Aridis expands research pact with CF Foundation for AR-501; US FDA grants fast track & QIDP designations for AR-501,   December 06, 2018
  Gilead's Harvoni receives Chinese approval to treat HCV genotype 1-6 infection,   December 06, 2018
  GlobalData says pharma companies may miss crucial EU drug packaging deadline in event of no-deal Brexit,   December 06, 2018
  US FDA accepts and grants priority review status to Roche's sBLA for Tecentriq in combo with chemotherapy for initial treatment of ES - SCLC,   December 06, 2018
  Sangamo Therapeutics completes acquisition of TxCell,   December 05, 2018
  AGC to acquire Malgrat Pharma Chemicals from Boehringer Ingelheim,   December 05, 2018
  Biotage buys US-based PhyNexus for US$ 21.5 million,   December 05, 2018
  Chugai Pharma receives Taiwan FDA approval for Hemlibra to treat haemophilia A with factor VIII inhibitors,   December 05, 2018
  GSK to buy Boston-based oncology focused biopharma company, Tesaro for US$ 5.1 billion,   December 04, 2018
  US FDA accepts Novartis BLA filing for Zolgensma and grants priority review status,   December 04, 2018
  EMA publishes revised guideline to assess risk of human medicines for environment,   December 03, 2018
  ViaCyte bags US$ 80 million Series D financing to advance functional cures for insulin-requiring diabetes,   December 01, 2018

Copyright © 2016 Saffron Media Pvt. Ltd |